De­nali touts more bio­mark­er da­ta with ac­cel­er­at­ed ap­proval in mind

He­paran sul­fate, a po­ten­tial new sur­ro­gate bio­mark­er for neu­rode­gen­er­a­tive dis­eases, is get­ting a lot of love from biotechs this week.

De­nali Ther­a­peu­tics on Wednes­day pre­sent­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER